SCHEMBL9508782

SCHEMBL9508782

CCCCOc1ccc(-c2ccc(C#Cc3ccc([C@H]4CC[C@H](CC)CC4)cc3)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.46
CYP3A4 P08684 3/20 0.43
CYP2D6 P10635 2/20 0.43
HRH3 Q9Y5N1 6/20 0.43
CYP2C9 P11712 3/20 0.43
NPC1 O15118 1/20 0.42
MCHR1 Q99705 1/20 0.42
ACACB O00763 2/20 0.41
HRH2 P25021 2/20 0.41
HRH1 P35367 2/20 0.41
CYP1A2 P05177 1/20 0.40
CYP19A1 P11511 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
CRBN Q96SW2 1/20 0.40
KCNH2 Q12809 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9511366 0.97 RAB9A (0.44) RAB9ACYP3A4CYP2D6HRH3CYP2C9
SCHEMBL9509022 0.96 RAB9A (0.49) RAB9ACYP3A4HRH3CYP2C9NPC1
SCHEMBL9510031 0.95 ACACB (0.44) RAB9ACYP2D6HRH3CYP2C9MCHR1
SCHEMBL9512418 0.93 RAB9A (0.47) RAB9ACYP3A4HRH3CYP2C9NPC1
SCHEMBL11282774 0.93 RAB9A (0.51) RAB9ACYP3A4CYP2D6HRH3CYP2C9
SCHEMBL9508732 0.91 RAB9A (0.45) RAB9ACYP3A4CYP2D6HRH3CYP2C9
SCHEMBL9512332 0.91 RAB9A (0.45) RAB9ACYP3A4CYP2D6HRH3CYP2C9
SCHEMBL9512374 0.91 ACACB (0.46) RAB9ACYP2D6HRH3CYP2C9ACACB
SCHEMBL11285603 0.91 RAB9A (0.49) RAB9ACYP3A4CYP2D6HRH3CYP2C9
SCHEMBL11278071 0.89 RARB (0.49) RAB9ACYP3A4CYP2D6HRH3CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0308438-B1 LIQUID CRYSTAL PHASE CONTAINING TOLANES MERCK PATENT GmbH (DE) 1993-09-29 EP disclosed